The state of Maryland is announcing a new initiative with the federal government to modernize the state's unique rate-setting system for hospital services.
The state of Maryland is announcing a new initiative with the federal government to modernize the state's unique rate-setting system for hospital services.
The agreement, which will be announced Friday by state and federal officials, is designed to move Maryland away from reimbursing hospitals on a fee-for-service basis to an emphasis on prevention and quality of care. Under the new plan, hospitals will do better financially as they provide high-quality care and help keep communities healthier, rather than being rewarded solely on the number of patients they treat, Dr. Joshua Sharfstein, Maryland's health secretary, said.
"It reflects a paradigm shift in the way that the healthcare system relates to public health," Sharfstein said. "Hospitals, doctors, nursing homes and many community health partners will all share in the same goal of improving health and controlling costs."
Read the full story here: http://bit.ly/1lImUqA
Source: Modern Healthcare
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care
May 26th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Listen